Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
New England Journal of Medicine
Biotech
Eisai rebuts report that Alzheimer's med contributed to death
A New England Journal of Medicine entry highlights a potential risk for patients taking Eisai's Alzheimer's med lecanemab.
Annalee Armstrong
Jan 4, 2023 5:33pm
Researchers unravel a potentially preventable genetic disease
Sep 30, 2021 8:45am
AbbVie's oral migraine treatment atogepant nears FDA decision
Aug 20, 2021 10:20am
Moderna data raise hopes for COVID-19 vaccine durability
Dec 4, 2020 8:12am
Tandem's artificial pancreas shows gains in children with T1D
Aug 31, 2020 8:10am
New Gilead remdesivir COVID-19 data show up old problems
Apr 13, 2020 7:00am